New technologies and procedures for cervical cancer screening

Area of Science:

• Gynecology
• Oncology
• Virology

Background:

• Human papillomavirus (HPV) DNA testing offers high sensitivity and reproducibility for detecting high-grade cervical intraepithelial neoplasia (CIN).
• Current HPV testing limitations include lower specificity, as it cannot differentiate transient from persistent infections, which are linked to cancer risk.
• Existing guidelines often restrict HPV testing to women over 30-35 years old due to specificity concerns.

Purpose of the Study:

• To explore novel approaches for enhancing the specificity of HPV testing in cervical cancer screening.
• To identify effective triage tests for HPV-positive women and potential primary screening alternatives.
• To review the progress and current status of emerging diagnostic methods for HPV infections.

Main Methods:

• Discusses HPV typing and methylation analysis for gene silencing as potential triage methods.
• Evaluates new cytologic methods like p16(INK4a) staining to identify proliferating cells.
• Reviews direct detection methods for HPV E6 or E7 proteins, visual inspection (VIA, VILI), and advancements in self-sampling techniques.

Main Results:

• New methods like HPV typing, methylation analysis, and p16(INK4a) staining show promise for improving specificity.
• Direct protein detection methods are in earlier stages of development.
• Visual inspection methods and self-sampling technologies are also being advanced.

Conclusions:

• Improving the specificity of HPV testing is crucial for its broader application in cervical cancer screening.
• Novel triage strategies and alternative primary screening methods are under development to overcome current limitations.
• Continued research into various diagnostic approaches, including molecular and visual methods, is essential for comprehensive HPV infection control.